STATIN THERAPY AND IMPROVED WAITLIST OUTCOMES IN LIVER TANS PANT CANDIDATES WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS

被引：0
|
作者：
Cooper, Katherine M.
Patel, Ami K.
Colletta, Alessandro
Devuni, Deepika
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
103
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [1] Impact of MELD 3.0 on waitlist outcomes of metabolic dysfunction-associated steatohepatitis cirrhosis among liver transplant waitlist registrants
    Sim, Benedix
    Lim, Wen Hui
    Tan, Darren Jun Hao
    Ng, Cheng Han
    Syn, Nicholas
    Nah, Benjamin
    Koh, Benjamin
    Xiao, Jieling
    Ong, Christen
    Koh, Jia Hong
    Tung, Daniel
    Huang, Daniel
    Siddiqui, Mohammad Shadab
    Muthiah, Mark
    Teng, Margaret
    JOURNAL OF HEPATOLOGY, 2024, 80 : S366 - S367
  • [2] Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis
    Cooper, Katherine M.
    Patel, Ami K.
    Zammitti, Christopher A.
    Murchie, Ellen
    Colletta, Alessandro
    Devuni, Deepika
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (02)
  • [3] 15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)
    Aminian, Ali
    ALJabri, Abdullah
    Wang, Sarah
    Bena, James
    Allende, Daniela
    Rosen, Hana
    Wilson, Rickesha
    Milinovich, Alex
    Loomba, Rohit
    Sanyal, Arun J.
    Alkhouri, Naim
    Wakim-Fleming, Jamile
    Dasarathy, Srinivasan
    McCullough, Arthur
    Nissen, Steven
    JOURNAL OF HEPATOLOGY, 2024, 80 : S76 - S77
  • [4] ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES?
    Kim, Do Han
    Ko, Donghyun
    Corral, Juan E.
    Kroner, Paul T.
    Lukens, Frank
    Argueta, Pedro Palacios
    GASTROENTEROLOGY, 2024, 166 (05) : S1663 - S1664
  • [5] SEPSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES AND HIGHER MORTALITY?
    Kim, Do Han
    Ko, Donghyun
    Argueta, Pedro Palacios
    Kroner, Paul T.
    Lukens, Frank
    Corral, Juan E.
    GASTROENTEROLOGY, 2024, 166 (05) : S1661 - S1662
  • [6] Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review
    Alnimer, Lynna
    Arellano, Diego
    Brombosz, Elizabeth
    Noureddin, Mazen
    LIVER TRANSPLANTATION, 2024,
  • [7] REAL-WORLD OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) COMPENSATED CIRRHOSIS AT A LARGE ACADEMIC REFERRAL CENTER
    Slatter, Shadera
    Guillot, Jordan
    Williams, Christopher
    Watanabe, Alexandre
    Chaudhri, Eirum
    Zhang, Xiao
    Fernandes, Gail
    Ge, Jin
    Rudrapatna, Vivek
    HEPATOLOGY, 2024, 80 : S860 - S861
  • [8] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
  • [9] Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis
    Aminian, Ali
    Aljabri, Abdullah
    Wang, Sarah
    Bena, James
    Allende, Daniela S.
    Rosen, Hana
    Arnold, Eileen
    Wilson, Rickesha
    Milinovich, Alex
    Loomba, Rohit
    Sanyal, Arun J.
    Alkhouri, Naim
    Wakim-Fleming, Jamile
    Laique, Sobia N.
    Dasarathy, Srinivasan
    Mccullough, Arthur J.
    Nissen, Steven E.
    NATURE MEDICINE, 2025, : 988 - 995
  • [10] Platelet dynamics in metabolic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and liver cirrhosis
    Zoncape, Mirko
    Castelli, Marco
    Sacerdoti, David
    Minuz, Pietro
    Dalbeni, Andrea
    JOURNAL OF HEPATOLOGY, 2024, 80 : S492 - S493
12345